Current Challenges in Hematology: The Biological and Therapeutic Advances in Chronic Myeloid Leukemia

Articles

BRIEF RESEARCH REPORT

Published on 08 May 2024

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

CASE REPORT

Published on 25 Mar 2024

A case report of atypical chronic myeloid leukemia with complete hematological and major molecular response to Venetoclax/Azacitidine treatment

MINI REVIEW

Published on 05 Mar 2024

The potential of circHIPK3 as a biomarker in chronic myeloid leukemia

ORIGINAL RESEARCH

Published on 21 Feb 2024

Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)

CASE REPORT

Published on 07 Feb 2024

Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine

REVIEW

Published on 20 Dec 2023

Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials

Share on

Frontiers in Oncology

Submit your idea